| Role |
Name |
Disclosure |
Details |
| Author | Michelle R Salvaggio, MD, Assistant Professor, Department of Internal Medicine, Section of Infectious Diseases, University of Oklahoma College of Medicine; Medical Director of Infectious Diseases Institute, University of Oklahoma Health Sciences Center | Merck | Details | | Coauthor | Peter S Miele, MD, Fellow, Department of Internal Medicine, Section of Infectious Diseases, Washington Hospital Center | Nothing to disclose | Details | | Coauthor | Margo A Smith, MD, Associate Program Director, Department of Medicine, Washington Hospital Center; Assistant Professor, Department of Internal Medicine, Section of Infectious Diseases, George Washington University | Nothing to disclose | Details | | Medical Editor | Thomas J Marrie, MD, Chair, Professor, Department of Medicine, Division of Infectious Diseases, University of Alberta College of Medicine | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Ronald A Greenfield, MD, Professor, Department of Internal Medicine, Section of Infectious Diseases, University of Oklahoma College of Medicine | Pfizer Gilead Ortho McNeil Wyeth Abbott Astellas Cubist | Details | | CME Editor | Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital | Nothing to disclose | Details | | Chief Editor | Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Margo A Smith, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Thomas J Marrie, Medical Editor |
The contributor discloses no conflict of interest. |
|